Position in PHVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$226,525,177
-$357,692 QoQ
Shares Held
6,550,757
-18.4% QoQ
Ownership
9.33%
of shares outstanding
% of Portfolio
7.79%
of 13F equity value
Holder Rank
#2
of 125 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHVS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GENERAL ATLANTIC, L.P. holds $541,727,121 across 5 Biotechnology names. PHVS ranks #1 (41.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHVS |
Pharvaris N.V.
This page
|
6,550,757 | $226,525,177 | |
| 2 | SPTX |
Seaport Therapeutics, Inc.
|
6,101,582 | $132,526,361 | |
| 3 | NRIX |
Nurix Therapeutics, Inc.
|
3,032,185 | $73,560,808 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
357,791 | $67,007,098 | |
| 5 | PBLS |
Parabilis Medicines, Inc.
|
1,538,461 | $42,107,677 |
All Filings in PHVS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $185,339,359 | 5,359,727 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $226,525,177 | 6,550,757 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $226,882,869 | 8,031,252 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $222,867,243 | 8,031,252 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $200,379,737 | 8,031,252 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $132,550,035 | 7,531,252 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $118,240,656 | 7,531,252 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $144,374,100 | 7,531,252 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $139,478,787 | 7,531,252 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $141,587,537 | 7,531,252 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $174,047,233 | 7,531,252 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $172,682,868 | 6,156,252 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $91,958,479 | 4,406,252 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $66,710,655 | 4,406,252 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $19,494,348 | 2,420,155 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $27,226,743 | 2,420,155 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $18,562,588 | 2,420,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $53,485,425 | 2,420,155 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $43,889,510 | 2,420,155 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,826,030 | 2,420,155 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $42,909,348 | 2,420,155 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $45,087,487 | 2,420,155 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $67,715,936 | 2,420,155 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||